Thursday, 29 Oct 2009
What follows is a roundup of corporate earnings reports for Friday, Oct. 30.
Swiss drug giant Novartis says it has redeployed 300 workers from other divisions into its vaccines unit to meet what Chairman and CEO Dr. Daniel Vasella calls the "huge demand" for H1N1 shots.
Thursday, 22 Oct 2009 | Source: Reuters
Merck, slated to acquire Schering-Plough later this year, reported better-than-expected earnings due to cost controls and strong sales of its diabetes and HIV treatments.
Thursday, 15 Oct 2009 | Source: CNBC.com
Wednesday, 30 Sep 2009 | Source: CNBC.com
The number-one H1N1 flu concern among U.S. businesses is the availability of a vaccine for employees, according to a new survey by the Business Roundtable.
Friday, 10 Jul 2009 | Source: The Associated Press
The Food and Drug Administration has approved a highly anticipated blood thinner from Eli Lilly after more than 18 months of review.
As flu season goes into high gear in the southern hemisphere, the U.S. Dept. of Homeland Security is preparing for a potential flu outbreak in the United States, according to its top official.
Friday, 15 May 2009 | Source: CNBC.com
The World Health Organisation warned on Friday against a false sense of security from waning and apparently mild outbreaks of H1N1 flu, saying the worst may not be over.
Posts |
COMPANY : Sanofi-Aventis SA
When I went to the FDA's Web site today I was surprised to see on the homepage a link to a letter written by Commissioner Dr... Read More
6 Nov 2009
Since when is profitability a prerequisite for speculation? Find out why Cramer thinks you should get in on this stock.... Read More
6 Nov 2009
Stacy and Clinton definitely had nothing to do with it, but Sanofi-Pasteur (the vaccines division of Sanofi-Aventis) greets visitors with a "What Not To Wear" brochure... Read More
28 Oct 2009
GlaxoSmithKline is one of the handful of drug companies on the front lines of the fight against the flu... Read More
16 Oct 2009
If you think your face is destined to sag with age think again... Read More
VIDEO | COMPANIES : Sanofi-Aventis SA
The $10.3 billion bid made by AXA SA and AMP for AXA Asia Pacific is a "compelling offer", says AXA SA's Asia Pacific CE...
Wayne Pisano, CEO of Sanofi-Pasteur, discusses the making of the flu vaccine with CNBC's Mike Huckman.
Flu vaccines were once a business that many drug companies avoided, but that segment of the pharma industry is now firml...
“We really are coping well with the crisis, and it’s not so hard,” Roland Paszkiewicz from PEKAO SA Brokerage House told...
While many doctors and at-risk individuals don't yet have access to the Swine Flu vaccine, certain employees at big NYC ...
More Videos
About CNBC | Site Map | Privacy Policy | Terms of Service | Video Reprints | Advertise | Help | Contact
Partners: AOL Money | BloggingStocks.com
Partners: AOL Money | BloggingStocks.com
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2009 CNBC, Inc. All Rights Reserved.
A Division of NBC Universal
